755 related articles for article (PubMed ID: 21267013)
1. Phenotypical and functional specialization of FOXP3+ regulatory T cells.
Campbell DJ; Koch MA
Nat Rev Immunol; 2011 Feb; 11(2):119-30. PubMed ID: 21267013
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.
Liu Y; Wang L; Predina J; Han R; Beier UH; Wang LC; Kapoor V; Bhatti TR; Akimova T; Singhal S; Brindle PK; Cole PA; Albelda SM; Hancock WW
Nat Med; 2013 Sep; 19(9):1173-7. PubMed ID: 23955711
[TBL] [Abstract][Full Text] [Related]
3. Functional stability of Foxp3+ regulatory T cells.
da Silva Martins M; Piccirillo CA
Trends Mol Med; 2012 Aug; 18(8):454-62. PubMed ID: 22771168
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
Koch MA; Tucker-Heard G; Perdue NR; Killebrew JR; Urdahl KB; Campbell DJ
Nat Immunol; 2009 Jun; 10(6):595-602. PubMed ID: 19412181
[TBL] [Abstract][Full Text] [Related]
5. Functional defect in regulatory T cells in myasthenia gravis.
Thiruppathi M; Rowin J; Li Jiang Q; Sheng JR; Prabhakar BS; Meriggioli MN
Ann N Y Acad Sci; 2012 Dec; 1274(1):68-76. PubMed ID: 23252899
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
[TBL] [Abstract][Full Text] [Related]
7. Functional plasticity in human FOXP3(+) regulatory T cells: implications for cell-based immunotherapy.
d'Hennezel E; Piccirillo CA
Hum Vaccin Immunother; 2012 Jul; 8(7):1001-5. PubMed ID: 22484225
[TBL] [Abstract][Full Text] [Related]
8. Foxp3+ regulatory T cells maintain immune homeostasis in the skin.
Dudda JC; Perdue N; Bachtanian E; Campbell DJ
J Exp Med; 2008 Jul; 205(7):1559-65. PubMed ID: 18573908
[TBL] [Abstract][Full Text] [Related]
9. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
10. Stability of the regulatory T cell lineage in vivo.
Rubtsov YP; Niec RE; Josefowicz S; Li L; Darce J; Mathis D; Benoist C; Rudensky AY
Science; 2010 Sep; 329(5999):1667-71. PubMed ID: 20929851
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
[TBL] [Abstract][Full Text] [Related]
12. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
Marson A; Kretschmer K; Frampton GM; Jacobsen ES; Polansky JK; MacIsaac KD; Levine SS; Fraenkel E; von Boehmer H; Young RA
Nature; 2007 Feb; 445(7130):931-5. PubMed ID: 17237765
[TBL] [Abstract][Full Text] [Related]
13. The role of natural regulatory T cells in infection.
Sanchez AM; Yang Y
Immunol Res; 2011 Apr; 49(1-3):124-34. PubMed ID: 21116872
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.
von Boehmer H; Daniel C
Nat Rev Drug Discov; 2013 Jan; 12(1):51-63. PubMed ID: 23274471
[TBL] [Abstract][Full Text] [Related]
15. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
Baratelli F; Lin Y; Zhu L; Yang SC; Heuzé-Vourc'h N; Zeng G; Reckamp K; Dohadwala M; Sharma S; Dubinett SM
J Immunol; 2005 Aug; 175(3):1483-90. PubMed ID: 16034085
[TBL] [Abstract][Full Text] [Related]
17. FOXP3+ regulatory T cells in the human immune system.
Sakaguchi S; Miyara M; Costantino CM; Hafler DA
Nat Rev Immunol; 2010 Jul; 10(7):490-500. PubMed ID: 20559327
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
[TBL] [Abstract][Full Text] [Related]
19. The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.
Kamikozuru K; Fukunaga K; Hirota S; Hida N; Ohda Y; Yoshida K; Yokoyama Y; Tozawa K; Kawa K; Iimuro M; Nagase K; Saniabadi AR; Nakamura S; Miwa H; Matsumoto T
Clin Exp Immunol; 2009 May; 156(2):320-7. PubMed ID: 19292766
[TBL] [Abstract][Full Text] [Related]
20. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
